Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
Clinical trial NCT05314998 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05314998
- Sponsor
- John Neoptolemos
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2031-01-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.